AI system
- System
-
ForeSight-HF (large-language-model clinical decision support on the ProviderLoop platform)
- Model
-
GPT-5 mini.
- Release
-
Exact release not established.
- Application developer
-
ProviderLoop (New York) with Mount Sinai clinicians
- Role
-
The model generated care recommendations for illustrative cases that the authors compared with actual treatment.
- Configuration
-
The authors accessed GPT-5 mini in late 2025.
- Inputs and outputs
-
Not assessed
- Autonomy
-
Not assessed
- Workflow
-
The researchers supplied unstructured nursing-home documentation to GPT-5 mini through ProviderLoop. Their proposed workflow includes physician review, but the two illustrated patients received care independently of the model. [1]
- Human oversight
-
Not assessed
- Relation to AI
-
The model generated illustrative recommendations for two selected cases. The authors expressly state that its outputs did not guide care. Case 2 describes differences between the recommendations and the treatment that clinicians actually provided. No prospective effect on treatment or health was tested. [1]
- AI contribution
-
The authors used the model to generate recommendations for two selected patients and state that its outputs did not guide care. They did not test whether the recommendations improved treatment or health. [1]
Benefits
- Outcome identifiers
-
Not assessed
- Benefit
-
ForeSight-HF recommended more diuretic treatment for one patient and less treatment for another. Clinicians managed both patients without using those recommendations. [1]
- Category
-
Improved Task Accuracy
- Status
-
Not assessed
- Beneficiary groups
-
People. Organizations. Society.
- Beneficiaries
-
Not assessed
- Reach
-
Not assessed
- Distribution and access
-
Not assessed
- Duration
-
Not assessed
- Expected?
-
Yes
- Costs and harms
-
Not assessed
Measurement
- Studies
-
Not assessed
- Study design
-
Not assessed
- Measurement
-
Not assessed
- Setting and sample
-
Not assessed
- Measures
-
Not assessed
- Comparison
-
Not assessed
- Results
-
Not assessed
- Additional value from AI
-
Not assessed
- Limitations
-
Not assessed
- Denominators
-
Not assessed
- Materials for replication
-
Not assessed
Money
- Kind of value
-
Not assessed
- Amount
-
Not assessed
- Currency and prices
-
Not assessed
- Period and unit
-
Not assessed
- Realization
-
Not assessed
- Recipients and payers
-
Not assessed
- Gross or net
-
Not assessed
- Included costs
-
Not assessed
- Comparison
-
Not assessed
- Method
-
Not assessed
- Return and payback
-
Not assessed
People and places
- Participants
-
Developer: ProviderLoop (New York) with Mount Sinai clinicians. Operator: Skilled nursing facilities served through the ProviderLoop platform (location not stated).
- Jurisdictions
-
Benefit: New York, New York, USA (authors).
- Ownership and control
-
Not assessed
- Dependencies
-
Not assessed
- Cross-border connections
-
Not assessed
- Geopolitical implications
-
Not assessed
Follow-up
- Conditions for replication
-
Prospective studies would need to test whether clinicians use the recommendations and whether patients benefit. An evaluation outside the developer’s team would help establish whether the findings hold elsewhere. [1]
- Replication attempts
-
Not assessed
- Later findings
-
The two illustrative cases were managed independently of the system for four months, and the cited source reports no later deployment data, trial or follow-up.
- Availability
-
Not assessed
- Institutional decision
-
Not assessed
- Grounds
-
Not assessed
- Action and result
-
Not assessed
- Success criterion
-
Not assessed
Evidence
- Source numbers
-
AIBD-0273-source-0001–0002 [1]
- Citations
-
Numbered references below. [1]
- Language
-
Not assessed
- Source relationships
-
Developer [1]
- Original evidence
-
The authors report two illustrative patients and state that the AI did not guide their care. They provide no raw clinical records or model logs. The cited clinical guidelines supply background rather than independent evidence about these patients. [1]
- Access and versions
-
The complete article is available in the publisher’s XML through Europe PMC, including its references and declarations. The article provides no supplementary dataset or appendix. [1]
- Supported findings
-
Not assessed
- Evidence links
-
Not assessed
- Evidence strength
-
Not assessed
- Missing evidence
-
Not assessed
Grades
- Assessed benefits
-
People. Organizations. Society.
- Depth
-
Not assessed
- Reasons
-
People: Both patients were managed independently of the AI system; outcomes not attributable. Organizations: No measured organizational effect; prospective validation is called for by the authors. Society: No attributable event.
- Observed or intended
-
Not assessed
- Rubric
-
Not assessed
- Assessor and date
-
Not assessed
- Alternative assessments
-
Not assessed
- Fill
-
The makers' claim
Entry details
- Kind
-
Not assessed
- Related entries
-
Not assessed
- Field
-
Health; post-acute cardiology. Heart-failure patients in skilled nursing facilities.
- Purpose
-
Generate heart-failure risk scores and management recommendations from nursing-facility documentation
- Dates
-
Source published: 3 June 2026. Updated: 24 October 2026. [1]
- Stage
-
Not assessed
- Version
-
SHA-256: eecc9714603d…
References
- Other identifiers
-
Not assessed
- Category mappings
-
Not assessed
- Brief
-
Not assessed
- Revisions
-
5 revisions. Latest: 24 October 2026. [1]
Sources
-
Case report Developer
Emma Glajchen et al., “AI-Driven Heart Failure Decision Support in Skilled Nursing Facilities,” JACC: Case Reports 31, no. 29 (2026): 108561, https://doi.org/10.1016/j.jaccas.2026.108561; online June 3, 2026, “Intended Use” and the two case descriptions.
Both retained quotations come from one vendor-affiliated case report, not two studies or independent confirmations.
The patient remained at the SNF for the following 4 months, managed independently of the AI system.
Dr Bander is the founder and holds an ownership interest in ProviderLoop, the platform on which ForeSight-HF was developed.